Cure COVID: A Prospective, Controlled, Randomized Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
Latest Information Update: 07 Nov 2022
At a glance
- Drugs Ezurpimtrostat (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms Cure COVID; CureCovid-2019
- Sponsors Genoscience
- 19 Feb 2022 This trial has been discontinued in Bulgaria (End Date: 06 Feb 2022), according to European Clinical Trials Database record.
- 19 Oct 2021 New source identified and integrated (European Clinical Trials Database: EudraCT2020-002249-40).
- 27 Jul 2021 Planned End Date changed from 30 Oct 2021 to 30 Dec 2021.